Celldex Therapeutics
CLDX
#4780
Rank
A$2.80 B
Marketcap
A$42.26
Share price
-5.74%
Change (1 day)
3.04%
Change (1 year)

Earnings for Celldex Therapeutics (CLDX)

Earnings in 2025 (TTM): -A$0.4 Billion

According to Celldex Therapeutics's latest financial reports the company's current earnings are A$2.6 Million. In 2024 the company made an earning of -A$0.3 Billion a decrease over its 2023 earnings that were of -A$0.22 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Celldex Therapeutics from 1986 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$0.4 Billion35.97%
2024 -A$0.3 Billion37.34%
2023 -A$0.22 Billion32.63%
2022 -A$0.17 Billion54.88%
2021 -A$0.11 Billion39.49%
2020 -A$74.58 Million-9.08%
2019 -A$82.03 Million-28.64%
2018 -A$0.12 Billion-30.11%
2017 -A$0.17 Billion-17.75%
2016 -A$0.2 Billion4.5%
2015 -A$0.2 Billion4.09%
2014 -A$0.19 Billion51.57%
2013 -A$0.13 Billion40.1%
2012 -A$86.57 Million
2010 -A$1.88 Million-96.59%
2009 -A$55.07 Million
2006 -A$33.65 Million
2004 -A$20.44 Million15.75%
2003 -A$17.66 Million-18.69%
2002 -A$21.71 Million-41.22%
2001 -A$36.94 Million59%
2000 -A$23.23 Million27.65%
1999 -A$18.2 Million53.12%
1998 -A$11.89 Million2.6%
1997 -A$11.59 Million-33.62%
1996 -A$17.45 Million-1.69%
1995 -A$17.76 Million22.92%
1994 -A$14.45 Million-0%
1993 -A$14.45 Million
1991 -A$8.88 Million90.32%
1990 -A$4.67 Million10.71%
1989 -A$4.22 Million833.33%
1988 -A$0.46 Million-400%
1987 A$0.15 M-125%
1986 -A$0.61 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Seagen
SGEN
-A$1.19 Billion 208.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
A$31.08 M-108.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A$0.24 B-164.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$12.40 B-3,317.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$17.82 B-4,725.35%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
A$14.02 B-3,738.35%๐Ÿ‡ฌ๐Ÿ‡ง UK
Titan Pharmaceuticals
TTNP
-A$4.22 Million-98.91%๐Ÿ‡บ๐Ÿ‡ธ USA